BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu Y, Wang H, Zhou L, Su Y, Shen W. Biodistribution, activation, and retention of proinsulin-transferrin fusion protein in the liver: Mechanism of liver-targeting as an insulin prodrug. Journal of Controlled Release 2018;275:186-91. [DOI: 10.1016/j.jconrel.2018.02.030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Pan K, Shi X, Liu K, Wang J, Chen Y. Efficacy, Pharmacokinetics, Biodistribution and Excretion of a Novel Acylated Long-Acting Insulin Analogue INS061 in Rats. Drug Des Devel Ther 2021;15:3487-98. [PMID: 34408401 DOI: 10.2147/DDDT.S317327] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Wei Y, Sun Y, Wei J, Qiu X, Meng F, Storm G, Zhong Z. Selective transferrin coating as a facile strategy to fabricate BBB-permeable and targeted vesicles for potent RNAi therapy of brain metastatic breast cancer in vivo. J Control Release 2021;337:521-9. [PMID: 34352315 DOI: 10.1016/j.jconrel.2021.07.048] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
3 Gu Y, Chen X, Zhang H, Wang H, Chen H, Huang S, Xu Y, Zhang Y, Wu X, Chen J. Study on the cellular internalization mechanisms and in vivo anti-bone metastasis prostate cancer efficiency of the peptide T7-modified polypeptide nanoparticles. Drug Deliv 2020;27:161-9. [PMID: 31913730 DOI: 10.1080/10717544.2019.1709923] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
4 Liu Y, Wang HY, Shao J, Zaro JL, Shen WC. Enhanced insulin receptor interaction by a bifunctional insulin-transferrin fusion protein: an approach to overcome insulin resistance. Sci Rep 2020;10:7724. [PMID: 32382087 DOI: 10.1038/s41598-020-64731-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kim Y, Min KA, Jang D, Ahn TY, Min JH, Yu BE, Cho KH. Practical approaches on the long-acting injections. J Pharm Investig 2020;50:147-57. [DOI: 10.1007/s40005-019-00452-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
6 Luo J, Zhang P, Zhao T, Jia M, Yin P, Li W, Zhang ZR, Fu Y, Gong T. Golgi Apparatus-Targeted Chondroitin-Modified Nanomicelles Suppress Hepatic Stellate Cell Activation for the Management of Liver Fibrosis. ACS Nano 2019;13:3910-23. [PMID: 30938986 DOI: 10.1021/acsnano.8b06924] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 11.5] [Reference Citation Analysis]
7 Venkatesan P, Thirumalaivasan N, Yu HP, Lai PS, Wu SP. Redox Stimuli Delivery Vehicle Based on Transferrin-Capped MSNPs for Targeted Drug Delivery in Cancer Therapy. ACS Appl Bio Mater 2019;2:1623-33. [PMID: 35026896 DOI: 10.1021/acsabm.9b00036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]